MGF (Mechano Growth Factor)

MGF (mechano growth factor) is a muscle-made cousin of a hormone called insulin-like growth factor 1 (IGF-1). The biology behind it is genuinely interesting, and there’s a believable story for how it could help muscles repair. But it’s sold as a research chemical — often in a tweaked form called PEG-MGF — based on that story and on animal studies, not on results in people. In short, the marketing is way out in front of the actual evidence.

What it is

Your body can read the IGF-1 gene in more than one way, producing slightly different versions of the protein (these versions are called splice variants). MGF is the version known as IGF-1Ec in humans (and IGF-1Eb in rodents). A small genetic change — a 49-base-pair insert in exon 5 — shifts how the gene is read, which creates a distinct tail-end piece called the E-domain peptide, or “MGF E-peptide” (roughly 24 amino acids long in humans). Most of this was figured out by Geoffrey Goldspink and his colleagues.

What makes MGF notable is the proposed biology. When a muscle is loaded mechanically or damaged, it briefly switches on MGF within hours — sooner than, and separately from, the steady, body-wide IGF-1Ea version. The idea is that MGF acts as a local repair signal (an “autocrine/paracrine” signal, meaning it works right where it’s made rather than traveling through the bloodstream). It’s thought to wake up resting satellite cells (muscle stem cells), push them to multiply, and hold off their maturing for a while — and then IGF-1Ea takes over to drive maturing, fusing, and building new muscle protein. The E-peptide also seems to do something on its own that doesn’t rely on the usual mature IGF-1 receptor (the docking site IGF-1 normally plugs into). It’s a tidy, well-referenced theory — not a proven effect in patients.

PEG-MGF is a lab-made synthetic version of the E-peptide with a polyethylene-glycol coating attached (a process called PEGylation) meant to make it last longer in the body, since the natural version breaks down very fast. It’s a “research chemical” built for the lab — not a tested, well-defined drug.

The claims

Sellers and online forums promote MGF and PEG-MGF for building muscle, recovering faster from training, switching on satellite cells, losing fat, and assorted “anti-aging” or metabolic perks. They’re usually pitched as proven results from an injectable peptide. They are not proven in humans.

What the evidence actually shows

The evidence here comes from mechanisms, cells in a dish, and animals. There’s essentially no human evidence from giving it to living people, and no completed human clinical trial of MGF or PEG-MGF used as a drug — no real trial registration and no published randomized controlled trial (a carefully designed study where people are randomly assigned to get the treatment or not) of MGF/PEG-MGF given to living people could be found. So treat any claim that it “works” clinically as unsupported.

Here’s what does exist:

• Human cells in a dish (not a clinical trial): In lab dishes of human muscle cells, the MGF E-peptide let satellite cells keep dividing for longer (delaying senescence — the point where cells stop dividing — and this was in cells from newborns and young donors, not older ones) and made them better at fusing together. This is dish-only work, with no dosing in people (Kandalla et al., Mechanisms of Ageing and Development, 2011).
• Mouse, brain: Producing extra MGF boosted the multiplying of neural stem cells in aging mouse brains — a result in genetically engineered animals, and one that’s about the brain, not muscle or metabolism (Tang et al., Molecular Brain, 2017).
• Mouse, ALS model: In SOD1(G93A) mice (a mouse model of ALS), MGF rescued motor nerve cells and improved muscle function (Riddoch-Contreras et al., Experimental Neurology, 2009). Animal only.
• A negative result: In a piglet growth-plate/cartilage-cell model, adding MGF from the outside had no effect on cell multiplying — a helpful reminder that the effects depend on the tissue and aren’t uniformly positive (Schlegel et al., PLoS One, 2013).

On fat loss and metabolic effects in particular, the evidence is thin to nonexistent: there’s no solid human data (or even strong animal data) showing MGF/PEG-MGF works for weight loss or metabolism. Any claims along those lines are guesswork.

Legal and regulatory status

MGF and PEG-MGF are not approved anywhere, for anything — no FDA, EMA, or other regulator has cleared them. They’re research-grade, preclinical compounds, not licensed medicines. Material sold online is labeled “research use only,” which means it can lawfully be sold only for genuine lab research — it is not a green light for people to use it.

In sport, MGF is flatly banned. It’s prohibited at all times — both in and out of competition — under the WADA Prohibited List, Section S2 (which covers peptide hormones, growth factors, and related substances and mimetics). The list names “mechano growth factors (MGFs)” by name, right alongside “insulin-like growth factor 1 (IGF-1) and its analogues,” in the growth-factors subsection (S2.3), and these are non-specified substances, which carry the strictest penalties. The 2026 list has been in force since January 1, 2026.

For comparison, not every popular compound is on the Prohibited List. GLP-1 receptor agonists are not banned. They sit on WADA’s Monitoring Program (semaglutide since 2024, with tirzepatide added for 2026), not the Prohibited List. So MGF is a fully banned growth factor, while GLP-1 agonists are just being watched and are still allowed.

Safety

The honest answer is that we basically don’t know how safe MGF is in people. There’s no human safety data from controlled trials, so calling it “well tolerated” isn’t backed by evidence for MGF.

The concerns that do exist are theoretical, borrowed from what we know about IGF-1 rather than proven for MGF. Because growth factors push cells to multiply, there’s a reasonable worry that MGF could feed the growth of an existing or hidden (occult) tumor. Effects on the heart (thickening of the heart muscle, called myocardial hypertrophy) and overgrowth of other tissue are also biologically plausible, but they haven’t been measured for MGF. On top of that, research-grade and PEG-MGF material bought outside the regulated supply chain comes with no guarantee of what’s actually in it — its identity, purity, sterility, and endotoxin (bacterial contamination) levels are all unverified. That’s a real-world hazard separate from how the peptide itself behaves. None of this is medical advice.

Bottom line

MGF has genuinely interesting and well-described biology — a muscle-triggered version of IGF-1 whose E-peptide plausibly acts as a local repair signal. But that’s mechanism and animal work, not results in people. It’s unapproved, has no completed human drug trials, has an unknown safety profile in humans, and is banned at all times in sport. The case for using it to build muscle, lose fat, or recover faster rests on extrapolation, not evidence.

Evidence grade: 3/10 · Animal only.

Sources

• Kandalla et al. 2011, Mechanisms of Ageing and Development — MGF E-peptide in human muscle cell cultures (PMID 21354439)
• Tang et al. 2017, Molecular Brain — MGF and neural stem-cell proliferation in aging mouse brain (PMID 28683812)
• Schlegel et al. 2013, PLoS One — IGF-1Ec/MGF in the growth plate; no proliferative effect (PMID 24146828)
• Riddoch-Contreras et al. 2009, Experimental Neurology — MGF rescues motoneurons in SOD1(G93A) mice (PMID 19038252)
• WADA 2026 Prohibited List (Section S2)
• WADA S2 detail — peptide hormones, growth factors and related substances (names MGFs)
• USADA — IGF-1 and the WADA Prohibited List (S2, prohibited at all times)
• WADA 2026 Monitoring Program — GLP-1s monitored, not prohibited (PDF)